Wabtec (WAB) reported disappointing Q4 2024 results with revenues of $2.58 billion, a 2.3% year-over-year increase but missing analyst expectations [2], [4], [5], [6]. This, coupled with missed EBITDA targets, led to a significant stock price decline of approximately 23% [2]. Despite these short-term challenges, the company highlighted a strong 2024 overall with growth in orders, sales, margins, earnings, and cash flow [5] and announced a 25% dividend increase [3], [7]. Long-term prospects are supported by strong organic revenue growth, expanding free cash flow margins, and new technology investments [1], [3]. However, Wabtec faces headwinds from a challenging macroeconomic environment and needs to address the concerns raised by the Q4 results [3].

Visa (V) is viewed favorably for its long-term growth prospects, driven by international expansion, new payment technologies, and a strong competitive moat [3], [4], [5]. Despite analysts' generally bullish views [1], recent stock performance has been lackluster, trailing the S&P 500 [6], and some consider it overvalued [6]. Positive earnings and revenue growth are expected [6], and the company's robust fundamentals and financial strength are highlighted [5], [8]. However, significant insider selling [9] and a cautious "In Line" rating from Evercore [7] temper enthusiasm. Upcoming Q2 2025 earnings results, scheduled for April 29th [10], will be a key catalyst for future stock movement. While Visa's long-term outlook appears positive, short-term uncertainty warrants a more measured approach.

Henry Schein (HSIC) will release Q1 2025 earnings on May 5th [2]. Despite a recent 5.5% stock price increase attributed to a broader market rally [1], the company faces a declining consensus EPS estimate and a Zacks Rank of #4 (Sell) [1], [8], with concerns over declining organic revenue, slim projected revenue growth, and declining return on invested capital [5]. While the company received validation for its net-zero emissions targets by 2050 [3] and will showcase its products at the 2025 International Dental Show [6], its stock has declined since its last earnings report [8] and underperformed the S&P 500, with analysts revising estimates downwards [8]. Long-term opportunities exist with potential increased demand for dental consumables due to Utah's water fluoridation ban [4] and a focus on sustainability [3], but negative recent financial performance [7] presents challenges.